MarketJohn Vane
Company Profile

John Vane

Sir John Robert Vane was a British pharmacologist who was instrumental in the understanding of how aspirin produces pain-relief and anti-inflammatory effects and his work led to new treatments for heart and blood vessel disease and introduction of ACE inhibitors. He was awarded the Nobel Prize in Physiology or Medicine in 1982 along with Sune Bergström and Bengt Samuelsson for "their discoveries concerning prostaglandins and related biologically active substances".

Education and early life
Born in Tardebigge, Worcestershire, John Vane was one of three children and grew up in suburban Birmingham. His father, Maurice Vane, was the son of Jewish Russian immigrants and his mother, Frances Vane, came from a Worcestershire farming family. He attended a local state school from age 5, before moving on to King Edward's School in Edgbaston, Birmingham. An early interest in chemistry was to prove the inspiration for studying the subject at the University of Birmingham in 1944. During his undergraduate studies, Vane became disenchanted with chemistry but still enjoyed experimentation. When Maurice Stacey, the Professor of Chemistry at Birmingham, was asked by Harold Burn to recommend a student to go to Oxford and study pharmacology, Vane jumped at the chance and moved to Burn's department in 1946. Under Burn's guidance, Vane found motivation and enthusiasm for pharmacology, writing: "[the] laboratory gradually became the most active and important centre for pharmacological research in the U.K. and the main school for training of young pharmacologists." supervised by Geoffrey Dawes. ==Career and research==
Career and research
After completing his DPhil, Vane worked as an assistant professor the Department of Pharmacology at Yale University before moving back to the United Kingdom to take up a post as a senior lecturer in the Institute of Basic Medical Sciences at the University of London in 1955. Wellcome Foundation In 1973, Vane left his academic post at the Royal College of Surgeons and took up the position as Director of Research at the Wellcome Foundation, taking a number of his colleagues with him who went on to form the Prostaglandin Research department. Under the leadership of Salvador Moncada, this group continued important research that eventually led to the discovery of prostacyclin. Return to academia In 1985, Vane returned to academic life and founded the William Harvey Research Institute at the Medical College of St Bartholomew's Hospital (now Barts and The London School of Medicine and Dentistry. At the William Harvey Research Institute, Vane's work focused on selective inhibitors of COX-2, and the interplay between nitric oxide and endothelin in the regulation of vascular function. ==Awards and honours==
Awards and honours
Vane was elected a Fellow of the Royal Society (FRS) in 1974. He was awarded the Lasker Award in 1977 for the discovery of prostacyclin and was knighted in 1984 for his contributions to science. In 2000, Vane received the Golden Plate Award of the American Academy of Achievement. ==Personal life==
Personal life
John Vane married, in 1948, (Elizabeth) Daphne Page and had 2 daughters. He died on 19 November 2004 in Princess Royal University Hospital, Kent, from long-term complications arising from leg and hip fractures he sustained in May of that year. Lady Vane died in 2021. == See also ==
tickerdossier.comtickerdossier.substack.com